Grantham, Mayo, Van Otterloo & Co (GMO)
ENOV icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Enovis ENOV Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ENOV Stock Details ENOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,574
Closed -$721K – 589
2017
Q4 		$721K Buy
+10,574
New +$712K ﹤0.01% 393

Other funds holding ENOV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Ashler Capital Chicago, Illinois $1.34B AUM 12.59% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ENOV Position: Q1 2018 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Enovis (ENOV) in Q1 2018, closing a stake of 10,574 shares — an estimated $721K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ENOV in Q4 2017 and held it in 1 quarter. The position peaked at $721K in Q4 2017. 203 funds tracked by Wall St. Rank hold ENOV as of Q1 2018.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Enovis position as of Q1 2018 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,574 Enovis shares in Q1 2018, an estimated $721K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Enovis in Q4 2017 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Enovis position peaked at $721K in Q4 2017.
  • 203 funds tracked by Wall St. Rank held Enovis as of Q1 2018.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2018, filed 15 May 2018.